Physician profile
Mark Holder
NPI 1659988533
$2,714.89
in general payments reported to CMS, 2019-2025
12 companies · $804 in 2025
The $804 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,153 · 2024: $757 · 2025: $804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,955 · Travel and Lodging: $760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,955.10 |
| Travel and Lodging | $759.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,082.75 | 2024-2025 | Intracept, General - Pain Management |
| Relievant Medsystems, INC. | $1,082.70 | 2023 | Intracept |
| Biotronik Nro, INC. | $135.48 | 2024-2025 | Prospera |
| Painteq LLC | $125.35 | 2024 | Painteq |
| Saluda Medical Americas, INC. | $106.76 | 2024-2025 | Evoke |
| Mml US, INC. | $46.64 | 2025 | Reactiv8 |
| Elite Orthopedics, LLC | $37.37 | 2023 | |
| Spinal Simplicity, LLC | $33.20 | 2025 | Ha Minuteman G3-R |
| Averitas Pharma INC. | $22.94 | 2025 | Qutenza |
| Regeneron Healthcare Solutions, INC. | $19.54 | 2023 | Dupixent |
| Spr Therapeutics, INC | $19.39 | 2023-2024 | Sprint Pns System |
| Abbott Laboratories | $2.77 | 2024 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Holder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.